| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.261 | 12.038 | 15.572 | 15.294 | 19.111 | 33.244 | 29.011 | 28.727 | 24.580 |
| Total Income - EUR | - | 8.446 | 12.059 | 16.775 | 15.294 | 19.111 | 33.244 | 29.169 | 28.806 | 24.680 |
| Total Expenses - EUR | - | 8.093 | 14.868 | 18.975 | 43.458 | 24.815 | 30.056 | 26.594 | 26.728 | 26.491 |
| Gross Profit/Loss - EUR | - | 353 | -2.809 | -2.200 | -28.164 | -5.703 | 3.188 | 2.575 | 2.078 | -1.811 |
| Net Profit/Loss - EUR | - | 100 | -5.544 | -2.603 | -28.559 | -6.004 | 2.855 | 2.174 | 1.790 | -2.552 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biamix Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 56.436 | 53.968 | 52.196 | 48.448 | 65.703 | 55.844 | 47.804 | 41.834 | 40.549 |
| Current Assets | - | 8.532 | 2.598 | 843 | 764 | 788 | 2.569 | 9.016 | 5.929 | 8.877 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 412 | 114 | 256 | 251 | 246 | 0 | 172 | 1.181 | 776 |
| Cash | - | 8.120 | 2.484 | 587 | 513 | 542 | 2.569 | 8.844 | 4.748 | 8.100 |
| Shareholders Funds | - | 144 | -5.402 | -7.906 | -36.312 | -41.628 | -37.849 | -35.793 | -33.894 | -36.257 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 64.824 | 61.968 | 60.945 | 85.525 | 108.119 | 96.263 | 92.613 | 81.657 | 85.682 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biamix Med Srl